Ashwagandha boosts memory and mood in clinical trial

FHS
June 11, 2024
3:01 am

A clinical trial found that acute and 30-day Ashwagandha supplementation improves cognitive function and mood markers, showing significant benefits in memory, attention, and well-being without adverse effects.

Viral host jumps: Humans to animals transmission more common than previously thought

The evolutionary mechanisms underpinning recent viral host jumps.

March 27, 2024

63% of Consumers Perceived Medical Billing as Challenging

What You Should Know: HealthLock, a leading medical fraud and overbilling protection solution, today unveiled insightful findings from a recent attitudinal study exploring how adults

July 26, 2023

FDA committee back Geron’s blood disorder drug – Pharmaceutical Technology

Share this article Geron’s blood disorder drug imetelstat is forecast to generate $1.2bn in sales in 2029, according to GlobalData. Credit: MacroEcon via Shutterstock. Advisers

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.